Primary |
Sepsis |
57.6% |
Septic Shock |
17.5% |
Multi-organ Failure |
5.1% |
Pneumonia |
3.9% |
Sedation |
2.1% |
Shock |
1.8% |
Abdominal Sepsis |
1.5% |
Prophylaxis |
1.5% |
Urosepsis |
1.3% |
Antibiotic Therapy |
1.0% |
Thrombosis Prophylaxis |
0.9% |
Infection |
0.8% |
Hypotension |
0.8% |
Meningococcal Sepsis |
0.8% |
Autoimmune Hepatitis |
0.7% |
Supplementation Therapy |
0.7% |
Anticoagulant Therapy |
0.6% |
Mechanical Ventilation |
0.6% |
Blood Antidiuretic Hormone |
0.5% |
Multiple Myeloma |
0.5% |
|
Death |
20.6% |
Thrombocytopenia |
15.4% |
Platelet Count Decreased |
10.2% |
Sepsis |
9.3% |
Septic Shock |
6.5% |
Multi-organ Failure |
5.5% |
Haemorrhage |
4.8% |
Cardiac Arrest |
3.3% |
International Normalised Ratio Increased |
3.2% |
Respiratory Failure |
3.2% |
Haemorrhage Intracranial |
3.0% |
Hypotension |
2.9% |
Subarachnoid Haemorrhage |
1.9% |
Gastrointestinal Haemorrhage |
1.8% |
Pulmonary Haemorrhage |
1.6% |
Cerebral Haemorrhage |
1.5% |
General Physical Health Deterioration |
1.5% |
Pneumonia |
1.5% |
Wound Haemorrhage |
1.3% |
Pulmonary Embolism |
1.1% |
|
Secondary |
Sepsis |
26.6% |
Septic Shock |
9.4% |
Drug Use For Unknown Indication |
7.8% |
Sedation |
7.0% |
Abdominal Sepsis |
6.3% |
Shock |
6.3% |
Thrombosis Prophylaxis |
6.3% |
Product Used For Unknown Indication |
5.5% |
Haemodynamic Instability |
3.1% |
Pneumonia |
3.1% |
Staphylococcal Sepsis |
3.1% |
Ill-defined Disorder |
2.3% |
Multi-organ Failure |
2.3% |
Antibiotic Therapy |
1.6% |
Blood Pressure Decreased |
1.6% |
Endotracheal Intubation |
1.6% |
Infection |
1.6% |
Prophylaxis |
1.6% |
Prophylaxis Against Transplant Rejection |
1.6% |
Renal Transplant |
1.6% |
|
Multi-organ Failure |
16.2% |
Sepsis |
10.8% |
Death |
9.5% |
Platelet Count Decreased |
8.1% |
Thrombocytopenia |
6.8% |
Tracheal Haemorrhage |
6.8% |
International Normalised Ratio Increased |
5.4% |
Ventricular Arrhythmia |
5.4% |
Pneumonia |
4.1% |
Troponin Increased |
4.1% |
Haemorrhage |
2.7% |
Medication Error |
2.7% |
Restlessness |
2.7% |
Septic Shock |
2.7% |
Therapy Non-responder |
2.7% |
Urinary Bladder Haemorrhage |
2.7% |
Wound Haemorrhage |
2.7% |
Clostridium Difficile Colitis |
1.4% |
Drug Ineffective |
1.4% |
General Physical Health Deterioration |
1.4% |
|
Concomitant |
Drug Use For Unknown Indication |
37.6% |
Sepsis |
10.6% |
Product Used For Unknown Indication |
9.9% |
Septic Shock |
7.8% |
Pneumonia |
5.0% |
Systemic Candida |
3.5% |
Depression |
2.8% |
Escherichia Bacteraemia |
2.8% |
Haemodynamic Instability |
2.8% |
Hypotension |
2.8% |
Staphylococcal Infection |
2.8% |
Bacteraemia |
1.4% |
Convulsion |
1.4% |
Deep Vein Thrombosis |
1.4% |
Endocarditis Staphylococcal |
1.4% |
Pain |
1.4% |
Preoperative Care |
1.4% |
Systemic Lupus Erythematosus |
1.4% |
Anaemia |
0.7% |
Anticoagulant Therapy |
0.7% |
|
Septic Shock |
18.2% |
Cytolytic Hepatitis |
12.1% |
Vasculitis |
9.1% |
Hypoglycaemia |
6.1% |
Pyrexia |
6.1% |
Toxic Epidermal Necrolysis |
6.1% |
Anxiety |
3.0% |
Breast Enlargement |
3.0% |
Cardio-respiratory Arrest |
3.0% |
Circulatory Collapse |
3.0% |
Death |
3.0% |
Disability |
3.0% |
Drug Ineffective |
3.0% |
Drug Level Decreased |
3.0% |
Eosinophilic Pneumonia |
3.0% |
Multi-organ Failure |
3.0% |
Ototoxicity |
3.0% |
Pneumonitis |
3.0% |
Purpura |
3.0% |
Rash Macular |
3.0% |
|